Shamburg News · 8-K filed Nov 16, 2026, 10:30 AM EST
INVO Fertility Reports Third Quarter 2026 Results With 26% Revenue Growth
IVF · INVO Fertility, Inc.
- Earnings
- Financial statements
- Materiality: high
On November 16, 2026, INVO Fertility, Inc. reported results for the quarter ended September 30, 2026, with total revenue of $2,222,656, up 26% from $1,757,094 a year earlier. Net loss narrowed to $2,149,920 from $3,395,598, and Clinic-Level Adjusted EBITDA was $292,114, its seventh consecutive positive quarter. Cash was $3,695,770 at September 30, 2026, and basic and diluted loss per share was $(2.44), compared with $(157.43) in the prior-year quarter.
Source: SEC EDGAR, Form 8-K, Items 2.02, 9.01, accession 0001493152-26-052109.
Written from the filing by Shamburg Markets. Figures are as reported by the company.